ClinicsCompoundsVendorsCompareBlogMethodology

Blog

Data-driven guides, vendor analysis, and research insights. No hype, no affiliate-first rankings. Just what the data shows.

Industry NewsGuidescompounds
Industry NewsMar 7, 2026

RFK Jr. Peptide Announcement - 14 Peptides Moving to Category 1 (What Actually Changed)

On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced that 14 peptides would be reclassified from Category 2 to Category 1 - but the formal FDA rule hasn't been published yet. Here's a fact-based breakdown.

Read more →
GuidesMar 7, 2026

Are Peptides Legal? Complete Regulatory Status Guide (March 2026)

The legal status of peptides is changing fast. Here's the current regulatory status of every major peptide - what you can legally buy, what requires a prescription, and what's still restricted.

Read more →
Industry NewsMar 7, 2026

FDA Peptide Status 2026 - Which Peptides Are Legal to Compound Now?

The FDA has reclassified multiple peptides since the 2023 Category 2 ban. Here is every compound's current legal status as of March 2026, and what comes next.

Read more →
GuidesMar 7, 2026

CJC-1295 Guide - Benefits, Dosing, Clinics & Where to Buy (2026)

CJC-1295 is the most searched GH peptide - now legally available through clinics. We compare CJC-1295 with DAC vs without, the Ipamorelin combo, clinic pricing, and research vendor costs.

Read more →
GuidesMar 7, 2026

Sermorelin in 2026 - Legal Status, Clinic Pricing & Where to Buy

Sermorelin is FDA Category 1 and legally available by prescription. We compare clinic pricing, research vendor costs, and how it stacks up against CJC-1295, Ipamorelin, and MK-677.

Read more →
GuidesMar 7, 2026

Tirzepatide in 2026 - Cost, Clinics, Research Vendors & What You Need to Know

Tirzepatide (Mounjaro/Zepbound) is FDA-approved and available through telehealth clinics starting at $150/month. We compare pricing across clinics and research vendors, break down the clinical trial data, and explain why the prescription route is the clear choice.

Read more →
GuidesMar 7, 2026

AOD-9604 - The Fat Loss Peptide That Skips the Growth Hormone Side Effects

AOD-9604 is a modified fragment of human growth hormone that targets fat metabolism without growth-promoting side effects. Here is what the research shows, how it compares to GLP-1 agonists, and where to get it legally in 2026.

Read more →
GuidesMar 6, 2026

Where to Buy Peptides in 2026 - Clinics, Vendors & What Is Legal

Looking for a reliable peptide supplier? We compared 20 vendors across purity testing, customer reviews, and price per mg to find the best sources.

Read more →
Industry NewsMar 6, 2026

Peptide Sciences Shuts Down - What It Means for the Research Peptide Market

The largest research peptide vendor shut down in March 2026. Finnrick E-rated their retatrutide, Trustpilot flagged multiple vendors, and the market is shifting to prescribed access.

Read more →
GuidesMar 6, 2026

Peptide Clinics vs Research Vendors - The Market Is Shifting (2026 Guide)

The peptide market is splitting in two: grey market research vendors and legitimate telehealth clinics. Here's how they compare and where things are heading.

Read more →
compoundsMar 6, 2026

MOTS-c: The Mitochondrial Peptide for Metabolism, Exercise & Aging (2026 Guide)

Read more →
compoundsMar 6, 2026

5-Amino-1MQ: The NNMT Inhibitor for Fat Loss and Metabolic Health (2026 Guide)

Read more →
GuidesMar 5, 2026

Peptide Purity Testing - How to Read a COA & Verify Vendor Quality

A COA is the single most important document when evaluating a peptide vendor. Here's how to read one - and what red flags to watch for.

Read more →
GuidesMar 2, 2026

Lyophilized vs Pre-Mixed Peptides - Which Form Should Researchers Choose?

Lyophilized powder or pre-mixed solution? We break down the stability, cost, and practical differences for peptide researchers.

Read more →

For research reference only. Not medical advice. Not for human consumption. All compounds discussed are research chemicals.